GigiGoesGugu (Talk | contribs) |
|||
| Line 5: | Line 5: | ||
''ELISA-like assay''<BR> | ''ELISA-like assay''<BR> | ||
-Beginning of the ELISA-like assay (for nanoparticles characterization). | -Beginning of the ELISA-like assay (for nanoparticles characterization). | ||
| + | |||
| + | <font size = "4"> Human practice </font> <BR> | ||
| + | |||
| + | ''Kit'' <BR> | ||
| + | - Remaking competent cells and transformation with AraC and constitutive-GFP plasmids according to the BioBuilder protocol. | ||
| + | |||
| + | - Starting the transformation with NEB 5-alpha competent cells. | ||
{{Template:EPFL2013Footer}} | {{Template:EPFL2013Footer}} | ||
Nanoparticles
ELISA-like assay
-Beginning of the ELISA-like assay (for nanoparticles characterization).
Human practice
Kit
- Remaking competent cells and transformation with AraC and constitutive-GFP plasmids according to the BioBuilder protocol.
- Starting the transformation with NEB 5-alpha competent cells.
"
